vs
DHT Holdings, Inc.（DHT）与SOLENO THERAPEUTICS INC（SLNO）财务数据对比。点击上方公司名可切换其他公司
DHT Holdings, Inc.的季度营收约是SOLENO THERAPEUTICS INC的1.6倍（$107.3M vs $66.0M），DHT Holdings, Inc.净利率更高（41.7% vs 39.4%，领先2.3%）
DHT控股是一家独立的国际原油运输企业，持有并运营大型原油运输船队，主要服务全球油气行业，为头部石油生产商、炼油厂和大宗商品贸易商提供跨国际核心贸易航线的原油海运服务。
索雷诺治疗是一家临床阶段生物制药企业，专注于开发针对罕见内分泌、代谢及神经发育疾病的创新疗法，核心在研药物用于治疗普拉德-威利综合征，服务覆盖北美、欧盟等地区的罕见病患者群体。
DHT vs SLNO — 直观对比
营收规模更大
DHT
是对方的1.6倍
$66.0M
净利率更高
DHT
高出2.3%
39.4%
损益表 — Q3 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $107.3M | $66.0M |
| 净利润 | $44.8M | $26.0M |
| 毛利率 | — | 98.3% |
| 营业利润率 | 44.2% | 33.5% |
| 净利率 | 41.7% | 39.4% |
| 营收同比 | -24.5% | — |
| 净利润同比 | 27.3% | 134.0% |
| 每股收益（稀释后） | $0.28 | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DHTSLNO
| Q3 25 | $107.3M | $66.0M | ||
| Q2 25 | — | $32.7M | ||
| Q3 24 | $142.1M | — | ||
| Q3 23 | $131.6M | — | ||
| Q3 22 | $109.9M | — |
净利润DHTSLNO
| Q3 25 | $44.8M | $26.0M | ||
| Q2 25 | — | $-4.7M | ||
| Q3 24 | $35.2M | — | ||
| Q3 23 | $31.0M | — | ||
| Q3 22 | $7.5M | — |
毛利率DHTSLNO
| Q3 25 | — | 98.3% | ||
| Q2 25 | — | 97.9% | ||
| Q3 24 | — | — | ||
| Q3 23 | — | — | ||
| Q3 22 | — | — |
营业利润率DHTSLNO
| Q3 25 | 44.2% | 33.5% | ||
| Q2 25 | — | -20.0% | ||
| Q3 24 | 29.7% | — | ||
| Q3 23 | 29.7% | — | ||
| Q3 22 | 11.1% | — |
净利率DHTSLNO
| Q3 25 | 41.7% | 39.4% | ||
| Q2 25 | — | -14.4% | ||
| Q3 24 | 24.8% | — | ||
| Q3 23 | 23.5% | — | ||
| Q3 22 | 6.8% | — |
每股收益（稀释后）DHTSLNO
| Q3 25 | $0.28 | $0.47 | ||
| Q2 25 | — | $-0.09 | ||
| Q3 24 | $0.22 | — | ||
| Q3 23 | $0.19 | — | ||
| Q3 22 | $0.04 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $81.3M | $498.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.1B | $494.8M |
| 总资产 | $1.4B | $599.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DHTSLNO
| Q3 25 | $81.3M | $498.9M | ||
| Q2 25 | — | $286.8M | ||
| Q3 24 | $73.8M | — | ||
| Q3 23 | $73.9M | — | ||
| Q3 22 | $65.7M | — |
股东权益DHTSLNO
| Q3 25 | $1.1B | $494.8M | ||
| Q2 25 | — | $240.1M | ||
| Q3 24 | $1.0B | — | ||
| Q3 23 | $1.0B | — | ||
| Q3 22 | $1.0B | — |
总资产DHTSLNO
| Q3 25 | $1.4B | $599.9M | ||
| Q2 25 | — | $332.3M | ||
| Q3 24 | $1.5B | — | ||
| Q3 23 | $1.5B | — | ||
| Q3 22 | $1.5B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.9M | $43.5M |
| 自由现金流经营现金流 - 资本支出 | — | $43.5M |
| 自由现金流率自由现金流/营收 | — | 65.8% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 1.36× | 1.67× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DHTSLNO
| Q3 25 | $60.9M | $43.5M | ||
| Q2 25 | — | $-12.6M | ||
| Q3 24 | $80.1M | — | ||
| Q3 23 | $55.7M | — | ||
| Q3 22 | $5.5M | — |
自由现金流DHTSLNO
| Q3 25 | — | $43.5M | ||
| Q2 25 | — | $-12.6M | ||
| Q3 24 | — | — | ||
| Q3 23 | — | — | ||
| Q3 22 | — | — |
自由现金流率DHTSLNO
| Q3 25 | — | 65.8% | ||
| Q2 25 | — | -38.6% | ||
| Q3 24 | — | — | ||
| Q3 23 | — | — | ||
| Q3 22 | — | — |
资本支出强度DHTSLNO
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q3 24 | — | — | ||
| Q3 23 | — | — | ||
| Q3 22 | — | — |
现金转化率DHTSLNO
| Q3 25 | 1.36× | 1.67× | ||
| Q2 25 | — | — | ||
| Q3 24 | 2.28× | — | ||
| Q3 23 | 1.80× | — | ||
| Q3 22 | 0.73× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
